CHINA
/
SOCIETY
China's phase 2 trial finds COVID-19 vaccine safe, inducing immune response: The Lancet
By Xinhua
Published: Jul 20, 2020 10:17 PM
Vaccine file photo:Xinhua
A phase 2 trial of a COVID-19 vaccine candidate conducted in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.
Please enable JavaScript to view the
comments powered by Disqus.
blog comments powered by
Disqus